» Articles » PMID: 30866413

Activation of COUP-TFI by a Novel Diindolylmethane Derivative

Overview
Journal Cells
Publisher MDPI
Date 2019 Mar 15
PMID 30866413
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is an orphan receptor and member of the nuclear receptor superfamily. Among a series of methylene substituted diindolylmethanes (C-DIMs) containing substituted phenyl and heteroaromatic groups, we identified 1,1-bis(3'-indolyl)-1-(4-pyridyl)-methane (DIM-C-Pyr-4) as an activator of COUP-TFI. Structure activity studies with structurally diverse heteroaromatic C-DIMs showed that the pyridyl substituted compound was active and the 4-pyridyl substituent was more potent than the 2- or 3-pyridyl analogs in transactivation assays in breast cancer cells. The DIM-C-Pyr-4 activated chimeric GAL4-COUP-TFI constructs containing full length, C- or N-terminal deletions, and transactivation was inhibited by phosphatidylinositol-3-kinase and protein kinase A inhibitors. However, DIM-C-Pyr-4 also induced transactivation and interactions of COUP-TFI and steroid receptor coactivators-1 and -2 in mammalian two-hybrid assays, and ligand-induced interactions of the C-terminal region of COUP-TFI were not affected by kinase inhibitors. We also showed that DIM-C-Pyr-4 activated COUP-TFI-dependent early growth response 1 (Egr-1) expression and this response primarily involved COUP-TFI interactions with Sp3 and to a lesser extent Sp1 bound to the proximal region of the Egr-1 promoter. Modeling studies showed interactions of DIM-C-Pyr-4 within the ligand binding domain of COUP-TFI. This report is the first to identify a COUP-TFI agonist and demonstrate activation of COUP-TFI-dependent Egr-1 expression.

Citing Articles

3,3'-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways.

Reyes-Hernandez O, Figueroa-Gonzalez G, Quintas-Granados L, Gutierrez-Ruiz S, Hernandez-Parra H, Romero-Montero A Cancer Cell Int. 2023; 23(1):180.

PMID: 37633886 PMC: 10464192. DOI: 10.1186/s12935-023-03031-4.


3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs.

Biersack B Cancer Drug Resist. 2022; 3(4):867-878.

PMID: 35582221 PMC: 8992569. DOI: 10.20517/cdr.2020.53.


Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome.

Bertacchi M, Tocco C, Schaaf C, Studer M Cells. 2022; 11(8).

PMID: 35455940 PMC: 9024734. DOI: 10.3390/cells11081260.


Role of Nuclear Receptors in Controlling Erythropoiesis.

Pastori V, Pozzi S, Labedz A, Ahmed S, Ronchi A Int J Mol Sci. 2022; 23(5).

PMID: 35269942 PMC: 8911257. DOI: 10.3390/ijms23052800.


Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.

Munoz-Tello P, Lin H, Khan P, de Vera I, Kamenecka T, Kojetin D J Med Chem. 2020; 63(24):15639-15654.

PMID: 33289551 PMC: 8006468. DOI: 10.1021/acs.jmedchem.0c00894.


References
1.
Kurihara I, Shibata H, Kobayashi S, Suda N, Ikeda Y, Yokota K . Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription. J Biol Chem. 2004; 280(8):6721-30. DOI: 10.1074/jbc.M411820200. View

2.
Zhang Y, Dufau M . Gene silencing by nuclear orphan receptors. Vitam Horm. 2004; 68:1-48. DOI: 10.1016/S0083-6729(04)68001-0. View

3.
Higgins K, Liu S, Abdelrahim M, Yoon K, Vanderlaag K, Porter W . Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins. Endocrinology. 2006; 147(7):3285-95. DOI: 10.1210/en.2006-0081. View

4.
Lannigan D . Estrogen receptor phosphorylation. Steroids. 2002; 68(1):1-9. DOI: 10.1016/s0039-128x(02)00110-1. View

5.
Shibata H, Nawaz Z, Tsai S, OMalley B, Tsai M . Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor.... Mol Endocrinol. 1997; 11(6):714-24. DOI: 10.1210/mend.11.6.0002. View